Amgen Inc. v. Ajanta Pharma Limited et al

REPLY BRIEF re MOTION to Dismiss for Failure to State a Claim Defendants' Counterclaim for Invalidity Under 35 U.S.C. §§ 101, 112, the Defenses Recognized in 35 U.S.C. § 282

D. Del.Jan 10, 2017